Ask AI
MATTERHORN OS
Phase III MATTERHORN: Final OS and EFS by Pathologic Outcomes With Durvalumab + FLOT vs Placebo + FLOT in Resectable Gastric/GEJ Cancer

Released: October 21, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: October 21, 2025